PatientsVille.com Logo

DYSGEUSIA and Prilosec

PatientsVille

DYSGEUSIA Symptoms and Causes

Our senses of taste and smell give us great pleasure. Taste helps us enjoy food and beverages. Smell lets us enjoy the scents and fragrances like roses or coffee. Taste and smell also protect us, letting us know when food has gone bad or when there is a gas leak. They make us want to eat, ensuring we get the nutrition we need.

People with taste disorders may taste things that aren't there, may not be able to tell the difference in tastes, or can't taste at all. People with smell disorders may lose their sense of smell, or things may smell different. A smell they once enjoyed may now smell bad to them.

Many illnesses and injuries can cause taste and smell disorders, including colds and head injuries. Some drugs can also affect taste and smell. Most people lose some ability to taste and smell as they get older. Treatment varies, depending on the problem and its cause.

NIH: National Institute on Deafness and Other Communication Disorders

Check out the latest treatments for DYSGEUSIA

DYSGEUSIA treatment research studies

Prilosec clinical trials, surveys and public health registries


Find Drug Side Effect reports



Prilosec Side Effects

Gastrooesophageal Reflux Disease (325)
Dyspepsia (259)
Nausea (231)
Malaise (199)
Abdominal Pain Upper (195)
Pain (188)
Vomiting (180)
Diarrhoea (177)
Headache (167)
Dyspnoea (163)
Dizziness (161)
Chest Pain (152)
Anxiety (134)
Fatigue (133)
Weight Decreased (127)
Off Label Use (122)
Injury (112)
Asthenia (111)
Abdominal Discomfort (107)
Abdominal Pain (105)
Depression (63)
Arthralgia (63)
Pain In Extremity (61)
Insomnia (60)
Dysphagia (59)
Feeling Abnormal (59)
Hiatus Hernia (56)
Incorrect Dose Administered (55)
Myocardial Infarction (53)
Flatulence (53)
Gastric Disorder (53)
Back Pain (52)
Cough (52)
Hypertension (49)
Hypersensitivity (48)
Muscle Spasms (47)
Constipation (47)
Condition Aggravated (44)
Cholecystitis Chronic (43)
Fall (42)
Throat Irritation (41)
Pneumonia (40)
Pruritus (40)
Cholelithiasis (39)
Eructation (39)
Dysgeusia (39)
Rash (38)
Oropharyngeal Pain (38)
Abdominal Distension (37)
Palpitations (36)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

DYSGEUSIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Dysgeusia;   Taste Disorders;   Lung Neoplasms;   Small Cell Lung Carcinoma
Intervention:
Outcome Measures: Dysgeusia;   Body composition;   Body Mass Index;   weight loss;   Subjective Global Assessment;   proportion of Anorexia;   energy and nutrimental consumption;   quality o f life
2 Recruiting Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy
Conditions: Colorectal Cancer;   Dysgeusia;   Oral Complications of Chemotherapy
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Biological: bovine lactoferrin
Outcome Measures: Change in the Taste Visual Analog Scale (VAS) and taste and smell questionnaire responses;   Effect of bovine lactoferrin on lipid peroxidation byproducts in saliva as measured by the TBARs assay;   Malondialdehyde (MDA) concentrations before and after a ferrous iron oral rinse;   Quality of life as quantified by the Functional Assessment of Anorexia/Cachexia Treatment (FAACT) questionnaire
3 Recruiting Taste Disorders in Middle Ear Disease and After Middle Ear Surgery
Condition: Taste Disturbance
Interventions: Other: taste measurement;   Other: Symptom questionnaire;   Behavioral: Quality of life questionnaire;   Other: Nerve sample
Outcome Measures: Taste disturbance;   Quality of life;   Histopathological changes
4 Recruiting Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
Conditions: Anorexia;   Cachexia;   Malignant Neoplasm;   Oral Complications of Chemotherapy
Interventions: Biological: bovine lactoferrin supplement;   Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
Outcome Measures: Change in taste disturbances using the visual analogue scale (VAS) and the Smell and Taste Questionnaire;   Change in smell disturbances using the VAS and the Smell and Taste Questionnaire;   Effect of bovine lactoferrin supplement on lipid peroxidation byproducts as measured by the TBARs assay;   Malondialdehyde (MDA) concentrations before and after a ferrous iron oral rinse;   Smelling loss as quantified by the Brief Smell Identification Test (B-SIT);   Quality of life as quantified by the Functional Assessment of Anorexia/Cachexia Treatment (FAACT) and Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) questionnaires
5 Recruiting Investigation of the Effects of Bariatric Surgery on Taste Reward in Humans
Condition: Obesity
Intervention:
Outcome Measures: Breakpoints;   Hunger;   Body mass index
6 Not yet recruiting Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Condition: Head and Neck Neoplasms
Interventions: Drug: Cetuximab;   Drug: Mitomycin-C/ 5-Fluorouracil
Outcome Measures: Quality of Life;   Efficacy of Cetuximab plus radiation therapy;   Equality in therapy of Cetuximab plus radiation therapy versus Mitomycin C/5-Fluorouracil plus radiation therapy.